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Abstract 26 
Human bocavirus 1 (HBoV1) and HBoV2-4 infect children and immunocompromised individuals, 27 
resulting in respiratory and gastrointestinal infections, respectively. Using cryo-electron 28 
microscopy and image reconstruction, the HBoV2 capsid structure was determined to 2.7 Å 29 
resolution at pH 7.4 and compared to the previously determined HBoV1, HBoV3, and HBoV4 30 
structures. Consistent with previous findings, surface variable region (VR) III of the capsid 31 
protein VP3, proposed as a host tissue-tropism determinant, was structurally similar among the 32 
gastrointestinal strains HBoV2-4, but differed from HBoV1 with its tropism for the respiratory 33 
tract. Towards understanding the entry and trafficking properties of these viruses, HBoV1 and 34 
HBoV2 were further analyzed as species representatives of the two HBoV tropisms. Their cell 35 
surface glycan-binding characteristics were analyzed, and capsid structures determined to 2.5-36 
2.7 Å resolution at pH 5.5 and 2.6, conditions normally encountered during infection. The data 37 
showed that glycans with terminal sialic acid, galactose, GlcNAc or heparan sulfate moieties do 38 
not facilitate HBoV1 or HBoV2 cellular attachment. With respect to trafficking, conformational 39 
changes common to both viruses were observed at low pH conditions localized to the VP N-40 
terminus under the 5-fold channel, in the surface loops VR-I and VR-V and specific side-chain 41 
residues such as cysteines and histidines. The 5-fold conformational movements provide insight 42 
into the potential mechanism of VP N-terminal dynamics during HBoV infection and side-chain 43 
modifications highlight pH-sensitive regions of the capsid. 44 
Importance 45 
Human bocaviruses (HBoVs) are associated with disease in humans. However, the lack of an 46 
animal model and a versatile cell culture system to study their life cycle limits the ability to 47 
develop specific treatments or vaccines. This study presents the structure of HBoV2, at 2.7 Å 48 
resolution, determined for comparison to the existing HBoV1, HBoV3, and HBoV4 structures, to 49 
enable the molecular characterization of strain and genus-specific capsid features contributing 50 
to tissue tropism and antigenicity. Furthermore, HBoV1 and HBoV2 structures determined under 51 
acidic conditions provide insight into capsid changes associated with endosomal and 52 
gastrointestinal acidification. Structural rearrangements of the capsid VP N-terminus, at the 53 
base of the 5-fold channel, demonstrate a disordering of a “basket” motif as pH decreases. 54 
These observations begin to unravel the molecular mechanism of HBoV infection and provide 55 
information for control strategies. 56 
Introduction 57 
The genus Bocaparvovirus, belonging to the Parvovirinae subfamily of the Parvoviridae 58 
family (1), was named after the first two virus members, bovine parvovirus (BPV) reported in 59 
1961 (2, 3) and canine minute virus (CnMV) isolated in 1967 (4). In 2005, a third member, 60 
human bocavirus 1 (HBoV1) was discovered in children (<2 years of age) suffering from acute 61 
respiratory tract infections (5). Three more human bocaviruses, HBoV2, HBoV3, and HBoV4, 62 
were subsequently isolated from pediatric patients with acute gastroenteritis (6-8). HBoV 63 
infections have been described worldwide in young children (7, 9-13), resulting in high 64 
seroprevalences of up to 80% for HBoV1 and 50% for HBoV2 already at the age of 6 years (14, 65 
15).     66 
The HBoV genomes contain three open reading frames (ORFs) (16, 17). ORF1 encodes a 67 
non-structural protein 1 (NS1) involved in genomic DNA replication (18). ORF2 encodes a 68 
phosphorylated nucleoprotein (NP) also important for DNA replication, capsid protein 69 
expression, and interferon signaling (19-21). ORF3 encodes three overlapping viral proteins, 70 
VP1 (~74 kDa), VP2 (~64 kDa), and VP3 (~60 kDa) (16, 17), which assemble the capsid, with 71 
T=1 icosahedral symmetry, from 60 VPs in an approximate 1:1:10 ratio (22). The VPs are 72 
expressed from different start codons within the same transcript and therefore share a common 73 
C-terminus (23-25). However, 60 copies of the common VP3 are capable of assembling capsids 74 
(26). Importantly, VP1 contains a unique N-terminal region (VP1u) containing a phospholipase 75 
A2 (PLA2) domain conserved in most parvoviruses (27). Its enzymatic activity is required for the 76 
capsid to escape the endo/lysosomal pathway after entry into host cells. The structure of the 77 
VP3 common region contains two α-helices (αA and αB) and an eight-stranded anti-parallel-β 78 
barrel (βB to βI) that forms the conserved core of the capsid. Large loops inserted between the 79 
β-strands form the exterior capsid surface (28, 29). These loops display the highest amino acid 80 
(aa) sequence variability and structural diversity among HBoV1, HBoV3, and HBoV4 capsids, 81 
and contain regions defined as variable regions (VRs) (28, 29). Characteristic features of the 82 
capsids include depressions at the icosahedral 2-fold axes and surrounding a channel at the 5-83 
fold axes, three separate protrusions that surround the 3-fold axes, and raised capsid regions 84 
between the 2- and 5-fold axes, termed the 2-/5-fold wall (28, 29).  85 
The HBoV capsid, as with other parvoviruses, serves as a protective coat for the 86 
packaged genome during the infection process that initiates with receptor attachment and 87 
cellular entry, involves trafficking in the endo/lysosomal pathway, nuclear entry, genome release 88 
and replication, transcription and translation, and ultimately capsid/virion assembly (30-32). For 89 
host cell recognition the capsid attaches to specific receptor(s) on the cell surface. With the 90 
exception of bovine parvovirus (BPV), reported to bind glycophorin A (GPA) with terminal α-2,3 91 
O-linked sialic acid on erythrocytes, nothing is known about cellular entry receptor usage by 92 
other bocaviruses (33). As shown for many other parvoviruses, the capsid traffics through the 93 
endo/lysosomal pathway, to the nucleus for genome replication, after cellular entry, and requires 94 
a pH gradient from the early endosome (pH 6.0), to late endosome (pH 5.5), and lysosome (pH 95 
4.0) conditions for successful infection (32). This acidification is reported to serve as a trigger for 96 
virus escape from the transport vesicles, utilizing the VP1u PLA2 enzymatic activity (31, 34). 97 
Similar to other parvoviruses, the bocavirus VP1u is postulated to become externalized through 98 
the 5-fold channel of the capsid, from the interior of the capsid, to enable its PLA2 function upon 99 
acidification of the endosomes (35-37).  100 
In this study, the capsid structure of HBoV2 was determined to 2.7 Å resolution by cryo-101 
electron microscopy (cryo-EM) and image reconstruction, and compared to the available capsid 102 
structures of HBoV1, HBoV3, and HBoV4 determined with the same method, to 2.9, 2.8, and 103 
3.0 Å resolution, respectively (28). The HBoV2 structure is similar to those of HBoV3 and 4, the 104 
other enteric viruses. All four structures, determined at neutral pH, exhibit surface loop topology 105 
differences in the VRs associated with tropism disparities (among parvoviruses), and all display 106 
a “basket” motif formed by the N-termini of VP3, extending the 5-fold channel into the capsid 107 
interior. The cell surface glycan-binding properties of HBoV1 and HBoV2 were also investigated 108 
and their structures determined at pH 5.5 and 2.6, to characterize the effect of pH acidification 109 
encountered during trafficking on the capsid structure. Column and cell binding-based assays 110 
failed to identify potential interacting glycans either because the cell attachment receptor does 111 
not contain a glycan, that the glycan recognized was not present in the array tested or the 112 
attachment site is not present in VP3. Comparison of the structures at pH 7.4, 5.5, and 2.6 113 
showed analogous disordering of the basket motif under the 5-fold channel, in addition to 114 
conformational changes at several surface loops, and modifications of cysteine and histidine 115 
amino acid side chains as pH drops. These changes suggest potential re-arrangements 116 
required for successful virus trafficking. Significantly, capsid stability measurements showed the 117 
highest thermal stability (Tm) at pH 5.5, suggesting that concurrent stabilization and re-118 
arrangements drive the capsid transitions required for infection, including the disordering of the 119 
5-fold basket motif, predicted to be necessary for externalization of the PLA2 function at low pH. 120 
This study provides insight into the mechanism(s) of HBoV infection and potential means to 121 
control HBoV spread. 122 
Results and Discussion 123 
 124 
The HBoV2 structure conserves features of other bocavirus members. HBoV2 VP3 virus-125 
like particles (VLPs) were generated using the baculovirus/Sf9 expression system, and 126 
produced and purified as previously reported (28) (see Methods section) in quantities and 127 
quality suitable for structural studies (not shown). The structure of HBoV2, at pH 7.4, was 128 
determined from a total of 188,857 capsid images, extracted from 2,921 micrographs. The 129 
individual capsid images were combined to reconstruct the capsid structure to 2.7 Å resolution 130 
(Fourier shell correlation (FSC) = 0.143 (Table 1)). The HBoV2 capsid density map exhibits 131 
surface capsid topology features shared by other known Parvovirinae subfamily members, 132 
including: a depressed region at the 2-fold axes; three protrusions surrounding the 3-fold axes; 133 
a cylindrical channel at the 5-fold axes, surrounded by a wide depressed region; and a "wall" 134 
between the 2- and 5-fold axes (22, 31) (Fig. 1A). A cross-sectional view of the HBoV2 capsid 135 
showed a “basket" beneath the 5-fold axes, a structural feature observed for BPV (29), HBoV1, 136 
HBoV3, and HBoV4 (28) (Fig. 1B). The HBoV2 amino acid side chains were well ordered in the 137 
core secondary structure (Fig. 1C) and most surface loop regions enabling most of VP3 to be 138 
built. Exceptions were missing side-chain densities for some residues at the apexes of some 139 
surface loops and acidic residues known to be most susceptible to radiation damage in cryo-EM 140 
(38). Furthermore, the first 32 residues of VP3 could not be built into the density map due to 141 
lack of ordering of the N-terminus. Similar to the other HBoV structures (28), the first ordered N-142 
terminal residue of VP3, residue 33, is located under the 5-fold channel projecting into the 143 
basket density extending into the interior of the capsid (Fig. 1D). The refined model, from 144 
residue 33 to the C-terminal residue 542, has a correlation coefficient (CC) of 0.83 to the 145 
reconstructed density map. The refinement statistics for the model are summarized in Table 1. 146 
The VP3 structure of HBoV2 displays the conserved core features of other parvoviruses (29), 147 
including an eight-stranded anti-parallel β-barrel (βB - βI) that is organized in two β-sheets, 148 
BIDG and CHEF with an additional βA strand that is anti-parallel to βB, and an α-helix (αA) 149 
between βB and βC (Fig. 2A). In addition, a second α-helix (αB) exists in the HBoV2 VP3 150 
structure located in one of the surface loops between the βE and βF (Fig. 2A), similar to other 151 
known bocavirus structures (28, 29).  152 
 153 
Comparison of HBoV VP3 structures at pH 7.4 supports a role for VR-III as a tropism 154 
determinant. The HBoV VPs have an amino acid sequence identity that ranges from 77 to 90% 155 
(7). Structural comparison of the different HBoV capsid structures showed that their core 156 
regions are nearly perfectly superposable (Fig. 2B). Furthermore, several VRs exhibit similar 157 
conformations, including VR-II, VI, VII, VIII, and IX (Fig. 2B). The remaining VRs, VR-I, VR-III, 158 
VR-IV, and VR-VIIIB, showed differences, with VR-III and VIIIB differing in HBoV1 due to a 4 aa 159 
insertion and an alternative conformation, respectively, and VR-IV in HBoV4 due to a 2 aa 160 
insertion as previously reported (28). Variable region I and VR-V differed among all HBoV 161 
strains despite the lack of insertions or deletions. Overall, the HBoV2 VRs resemble those of 162 
HBoV3 with a minor difference in VR-V (Fig. 2B), with an overall CD RMSD of 0.66 Å for their 163 
superposed VPs. HBoV4 displays structural differences to HBoV2 in VR-I, IV, and V (Fig. 2B), 164 
and is the next most structurally similar with an overall VP CD RMSD of 0.78 Å. HBoV1, has the 165 
lowest sequence similarity and a different tissue tropism compared to the gastrointestinal 166 
HBoVs and also exhibits the greatest VP CD RMSD of 1.13 Å compared to HBoV2. Previously, 167 
it was postulated that VR-III, displaying the highest structural difference between the respiratory 168 
and the gastrointestinal HBoVs, might be a determinant for tissue tropism (28). HBoV2 169 
conserves the structure of this loop in the gastrointestinal HBoVs. In contrast to the other 170 
surface loops, the aa sequence of VR-III, residues 196-IHELAEMED(A/S)NAVEKAI-212, is 171 
highly conserved among HBoV2, HBoV3, and HBoV4. This further highlights the potential 172 
importance of VR-III for tissue tropism. VR-III is located at the 2-5-fold wall of the capsid where 173 
other parvoviruses are also known to bind to glycan receptors, e.g. AAV1 to sialic acid (39) or 174 
AAV9 to terminal galactose (40). This capsid region along with VR-I, VR-IV, VR-V, and VR-VIII 175 
also serve as dominant antigenic regions (41). HBoV-based vectors are currently being 176 
developed as vectors for gene therapy applications (42). The structure information for HBoV2, 177 
along with those already available for the other HBoV strains (28), will assist future engineering 178 
of vectors to reduce the detrimental effects of pre-existing immunity, and improve or alter the 179 
tropism as recently shown for HBoV1 (43). 180 
 181 
HBoV1 and HBoV2 VP3 VLPs do not bind common cell surface glycans. To date, no viral 182 
entry receptors have been identified for any of the HBoVs. To characterize whether the HBoVs 183 
use glycans as receptors, HBoV1 and HBoV2, the two most widely distributed HBoVs 184 
representing the two HBoV tropisms and disease phenotypes (5, 7), were analyzed. Heparin-185 
binding assays, to mimic heparan sulfate proteoglycan (HSPG) interactions, utilizing VLPs, were 186 
performed (Fig. 3A) in addition to cell-binding assays with fluorescently labeled VLPs (Fig. 3B). 187 
AAV2 VLPs known to bind HSPG (44) and AAV5 VLPs that do not bind to HSPGs but bind to 188 
terminal sialic acid (45), were used as controls. In the heparin-binding assays, AAV2 VLPs 189 
appeared in the elutions fraction consistent with binding while AAV5 and the HBoV1 and HBoV2 190 
VLPs were detected in the wash and flowthrough fractions indicating lack of binding (Fig. 3A). 191 
Cell-binding assays, to analyze binding to terminal sialic acid, galactose, or N-192 
acetylglucosamine, utilized differential glycan-presenting CHO cell lines. The parental CHO-193 
Pro5 cell line displays terminal sialic acid, the mutant Lec2 cell line displays terminal galactose, 194 
and the Lec8 cell line displays N-acetylglucosamine, resulting from mutations in specific genes 195 
required for glycan biosynthesis (46). AAV5 that is known to bind to sialic acid (45) only bound 196 
to Pro5 cells whereas AAV2, which binds to HSPG (44) and does not require any of the glycans 197 
affected by the mutations of the CHO cell lines, bound to all three cell lines with approximately 198 
equal efficiency (Fig. 3C). In contrast, both HBoV1 and HBoV2 showed no significant binding to 199 
any of the three cell lines, indicating that they do not use terminal sialic acid, galactose, or N-200 
acetylglucosamine as receptors (Fig. 3C). In addition, a series of colon cell lines: HT-29, CaCo-201 
2, and CMT-93 and the lung cell line A549, were analyzed (Fig. 3C). While AAV2-VLPs bound 202 
efficiently to all these cells, AAV5 showed weak to medium binding phenotypes and both HBoV1 203 
and HBoV2 showed no significant binding (Fig. 3C). These observations indicate that these 204 
viruses might require additional cofactors for cellular attachment such as bile salts or microbial 205 
molecules as described recently for noroviruses (47). It could also be that they do not utilize 206 
glycans for cellular entry or that, unlike AAV2 and AAV5, VP3 alone does not contain the glycan 207 
binding determinant and VP1 is required, as reported for B19 (48). 208 
 209 
HBoV1 and HBoV2 capsids reveal strain-specific as well as common phenotypes under 210 
pH environments associated with infection. During infection and trafficking, HBoVs 211 
encounter different cellular environments. HBoV1, is exposed to the mild acidic pH conditions in 212 
the respiratory tract ranging from pH 5.5 to 6.7 (49). In contrast, HBoV2-HBoV4, associated with 213 
gastrointestinal infections, are initially exposed to the acidic extracellular environment of the 214 
stomach, ranging from pH 1.5 to 3.5 (50). While experiencing these varied extra-cellular pH 215 
conditions the capsids have to remain structurally intact to infect cells. In addition, the HBoVs all 216 
also experience varied pH conditions after cellular internalization while trafficking through the 217 
early (pH 6) and late endosome (pH 5.5), lysosome (pH 4), and then nucleus (pH 7.4). In order 218 
to confirm that HBoV1 and HBoV2 capsids are indeed intact at these conditions the VLPs were 219 
dialyzed into different pH environments and analyzed by negative-stain EM. The result showed 220 
that the capsids were visually intact in all the pHs tested, even with multiple changes of pH 221 
conditions (from pH 7.4 to 2.6 and back to 7.4) (Fig. 4A and B).    222 
To further analyze the stability of the capsids at the different pH environments the 223 
melting temperature (TM) of the HBoV VLPs were determined by differential scanning fluorimetry 224 
(DSF) with previously characterized AAV5 VLPs for direct comparison. The TM of AAV5 at pH 225 
7.4 has been reported to be 89.0 ± 0.1°C (in Universal buffer, see methods for ingredients) (51) 226 
and confirmed here (TM of 89.5°C, Fig. 4C). At lower pH conditions the TM of AAV5 gradually 227 
decrease; 89.5°C at pH 7.4, 88.0°C at pH 6.0, 80.5°C at pH 5.5, 78.0°C at pH 4.0, and 71.5°C 228 
at pH 2.6. The thermal stability of AAV5 capsids has also been analyzed in citric phosphate 229 
buffer at pH7.4, 6.0, 5.5, and 4.0 with comparable results (37). The thermal stability profile of 230 
HBoV2 followed a similar trend to AAV5, however at lower temperatures, with the TM decreasing 231 
with pH; 73.2°C at pH 7.4, 70.3°C at pH 6.0, 70.0°C at pH 5.5, 67.8°C at pH 4.0, and 43.5°C at 232 
pH 2.6 (Fig. 4C). The HBoV1 profile differed in that it’s TM increased as pH dropped and then 233 
decreased again: 65.3°C at pH 7.4, 68.7°C at pH 6.0, 69.7°C at pH 5.5, and then reduced to 234 
67.0°C at pH 4.0 and 41.3 °C at pH 2.6. A similar trend was previously observed for AAV1, 235 
AAV2, and AAV8 (37). The capsid stability is reversible, for example, when dialyzed from pH 2.6 236 
to 7.4 (Fig. 4C). 237 
The TM of the two HBoVs differed most at pH 7.4, by ~8°C, and by only ~2°C from pH 6 238 
to 2.6, with HBoV2 being the most stable. The difference at pH 7.4 is consistent with the utility of 239 
TM for identifying AAV serotypes (52) and suggests that the HBoVs can be similarly 240 
differentiated by TM. Notably, the VP1u and VP1/2 common regions of VP1 and VP2 do not 241 
contribute to AAV capsid stability, and this phenotype is likely the same for the HBoVs. Despite 242 
the lack of minor VPs in the HBoV VLPs, the maintained stability of the capsids at pH 6.0 and 243 
5.5 is consistent with the need to preserve integrity under the conditions where the PLA2 domain 244 
within the VP1u is proposed to be externalized for endo/lysosomal escape (53). The reversibility 245 
of the pH effects on the capsid, from a destabilized low pH environment to pH 7.4, provides 246 
insight into the requirements to escape into the cytoplasm and travel into the nucleus while 247 
protecting the genome. 248 
 249 
The capsid structure of HBoV1 and HBoV2 at pH 2.6 and 5.5 reveals capsid dynamics 250 
associated with endo/lysosomal escape. To further analyze the observed contrasting capsid 251 
stabilities at pH 2.6 and 5.5, the structures of HBoV1 and HBoV2 were determined at these pHs 252 
to identify any associated structural differences. VLPs were dialyzed to the two pH conditions 253 
and vitrified on EM grids for data collection. For HBoV1 50,342 capsids were selected at pH 2.6 254 
and 66,471 capsids at pH 5.5 resulting in a three-dimensional (3D) reconstructed capsid 255 
structure at 2.54 and 2.74 Å resolution, respectively (Table 1). Similarly, for HBoV2, 19,648 and 256 
30,308 capsids were selected at pH 2.6 and pH 5.5 for a 3D-reconstructed capsid structure at 257 
2.51 and 2.74 Å resolution, respectively (Table 1). 258 
  Comparison of the HBoV1 and HBoV2 maps at pH 2.6 and 5.5, with the previously 259 
published pH 7.4 HBoV1 map (28) and the map of HBoV2 described above, showed minor 260 
structural differences on the capsid exterior surface but significant movement of the VP3 N-261 
terminus (Fig. 5, 6 and 7). The capsid surface differences are located at the 2-5-fold wall (VR-I) 262 
and 3-fold protrusions (VR-V) of the HBoV1 and HBoV2 capsids at pH 2.6 compared to pH 7.4 263 
and 5.5 (Fig. 6), with HBoV2 showing additional density at the 3-fold symmetry axis at pH 2.6 264 
(Fig. 5). On the capsid interior, the ‘basket’ structure beneath the 5-fold axis at pH 7.4 becomes 265 
less pronounced at pH 2.6, suggesting that low pH induces movements of the VP3 N-terminus 266 
for both HBoV1 and HBoV2 (Fig. 5). Interestingly, low resolution cryo-EM structures of both 267 
capsids returned to pH 7.4 from 2.6 showed the reappearance of the basket structure and loss 268 
of the 3-fold density in HBoV2 (data not shown), implying that these structural observations are 269 
reversible. This would be consistent with the requirement to maintain capsid integrity following 270 
VP1u externalization to protect the encapsulated genome en route to the nucleus for replication. 271 
 Similar to pH 7.4, the low pH structures were ordered from residue 33 to the C-terminus, 272 
residue 542 in HBoV1 and 537 in HBoV2. The CCs for the models fitted into their respective 273 
maps ranged from 0.80 to 0.87 (Table 1). The RMSDs for HBoV1 are 0.6 Å (pH 5.5) and 0.7 Å 274 
(pH 2.6) for CD atoms compared to the pH 7.4 structure. As reported previously, two regions of 275 
the HBoV1 pH 7.4 map, residues 204-209 (VR-III) and 333-338 (VR-V), were poorly ordered, 276 
and only the main chain interpreted. Similarly, the HBoV1 map at pH 2.6 displayed disordered 277 
density in these loops and as well as residues 78-84 (VR-I) (Fig. 6A and C). Despite the high 278 
level of disorder in these loops, the main chain was interpretable (Fig. 6A and C). In contrast to 279 
the pH 2.6 and pH 7.4 HBoV1 maps, the pH 5.5 density was better ordered in these loops with 280 
most side-chain densities observed (Fig. 6A and C). Overall, the HBoV1 VP structure topology 281 
was similar at all three pH conditions analyzed except for conformational shifts in VR-I and VR-282 
V (Fig. 6E). These structural shifts were more pronounced for pH 2.6 with main chain 283 
movements of ~9 Å in both VR-I and VR-V compared to pH 7.4, and ~3 Å in VR-I and ~7 Å in 284 
VR-V between pH 5.5 and 7.4. These observations identify the 2/5-fold wall and 3-fold 285 
protrusions of the capsid as being involved in the capsid dynamics associated with low pH-286 
mediated transitions required for infection. 287 
For the HBoV2 pH 5.5 and 2.6 structures the overall RMSDs for their VP superposed 288 
onto the pH 7.4 coordinates is 0.4 and 0.7 Å, respectively, for CD atoms. The HBoV2 surface 289 
loops were generally more ordered at pH 7.4 and 5.5 compared to those of HBoV1 (Fig. 6A-D). 290 
At pH 2.6, VR-V was slightly disordered and only the main chain interpreted (Fig. 6D). Similar to 291 
HBoV1, the overall capsid structure was maintained with low pH-dependent shifts of the main 292 
chain observed in VR-I and VR-V. These shifts are also more pronounced at pH 2.6, with main 293 
chain movements of ~4 Å in VR-I and ~6 Å in VR-V compared to pH 7.4, and <2 Å in VR-I and 294 
<3 Å in VR-V at pH 5.5 compared to pH 7.4. Thus, the HBoV2 capsid is susceptible to reduced 295 
pH-induced conformational changes compared to HBoV1. This could be an adaptation to the 296 
potential fecal-oral transmission route involving the acidic conditions of the stomach. In addition, 297 
the pH-sensitive regions of the HBoV capsids, VR-I and VR-V, located at the side of the 2/5-fold 298 
wall and 3-fold protrusions, is known to bind to various receptors in other parvoviruses (39, 40, 299 
54, 55). The pH-induced movement of these loops may enable the capsid to detach from its 300 
receptor after cell entry and acidification of the endosomes. 301 
 302 
The HBoV VP N-terminus experiences pH-induced conformational changes. The basket-303 
like structure of the HBoVs under the 5-fold channel (Fig. 1D) is formed by the glycine-rich N-304 
terminus of VP3 (28). The high number of glycine residues grouped at the N-terminus of the 305 
major VP is a common element among the parvoviruses (22). However, among the parvoviral 306 
structures determined to date only the bocaviruses (28, 29), AAV5 in complex with an antibody 307 
(56), and Penaeus monodon metallodensovirus (57) display this feature. The clustering of 308 
glycines is believed to provide flexibility to the N-terminus for the externalization of the VP1u 309 
region with its PLA2 domain through the 5-fold channel. The presence of the basket could thus 310 
be thought to prevent premature externalization, acting as a "cork" to the 5-fold channel, or as 311 
the region positioned to initiate the process. However, the basket is still present at pH 5.5 (Fig. 5 312 
and 7), the condition encountered by capsids during endosomal acidification and is thought to 313 
be associated with the externalization of the VP1u region. At pH 2.6 the basket under the 5-fold 314 
channel disappears, with density observed leading away from the 5-fold channel, on the capsid 315 
interior surface, interpreted as aa24-29 of the VP3 N-terminus (Fig. 5 and 7). This density runs 316 
antiparallel to the βG strand in both HBoV1 and HBoV2 (Fig. 7B and D) and possesses several 317 
glycines on both ends. It is possible that this movement away from the 5-fold channel (Fig. 7E 318 
and F) is a mechanism to prevent premature externalization of VP1u, or that externalization is 319 
via a different portal, for example, the 2-fold axis. However, these studies were performed on 320 
HBoV VP3-only VLPs. The wild-type capsid contains, on average, 50 copies of VP3, 5 of VP1, 321 
and 5 of VP2 with extended N-terminus of 129 and 35 aa, respectively. Due to the 322 
incompatibility of the number of VP1 and VP2 with icosahedral symmetry (imposed during 323 
structure determination), their structures would also be absent in the density map of wild-type 324 
capsids (22). Nonetheless, in future studies, it would be interesting to see whether VP1 and VP2 325 
has an effect on the basket structure under the 5-fold channel.  326 
  327 
pH-induced residue level changes targets cysteines and histidines. In addition to structural 328 
shifts described above a number of side chain rotamer changes and unassigned densities 329 
proximal to side chains were observed in the HBoV1 and HBoV2 pH 2.6 and 5.5 maps 330 
compared to pH 7.4 (Fig. 8). The amino acids affected the most are cysteines and histidines. 331 
The HBoV1 and HBoV2 VP3 contains a total of 10 and 8 cysteines, respectively. None of these 332 
are in close enough proximity to form disulfide bonds. However, in HBoV1, at pH 5.5 and 2.6, 333 
two and eight cysteines, respectively, exhibited modifications or additional density, not 334 
consistent with the cysteine side chain alone, as seen at pH 7.4 (Fig. 8A and B, Table 2). 335 
Similarly, the same observation was made for HBoV2, with three cysteines at pH 5.5 and five at 336 
pH 2.6 exhibiting additional density (Fig. 8A and B, Table 2). In some cases, the additional 337 
density on the cysteines caused steric clashes with neighboring amino acids resulting in 338 
conformational shifts of amino acid side chains. For example, conserved C159’s modification 339 
flips the orientation of a nearby phenylalanine (F234 in HBoV1; F239 in HBoV2) at pH 5.5 and 340 
2.6 (Fig. 8A). Generally, conserved cysteines showed modifications in both HBoVs except for 341 
C473 in HBoV2 that did not show any additional densities unlike structurally equivalent C477 in 342 
HBoV1 (Fig. 8B). This density extends to nearby C104, not conserved in HBoV2 (Table 2), and 343 
M177 in HBoV1. Vice-versa there were also unique cysteine densities in HBoV2, e.g., C393 344 
(valine in HBoV1), modified by additional density. This cysteine is located near the 3-fold 345 
symmetry axis (Fig. 8B). The three symmetry-related cysteines created the large extra density 346 
seen at the center of the 3-fold axis (Fig. 5 and 8B). Generally, the cysteines with modifications 347 
in the HBoV1 and HBoV2 capsids are located either on the exterior or interior surface of the 348 
capsid (Fig. 8C and D) and are located in hydrophobic environments. In contrast, unmodified 349 
cysteines are either buried or situated in less hydrophobic regions (not shown). 350 
The cysteine modification phenomenon appears to be independent of the buffer used, 351 
because glycine-HCl was used at pH 2.6 and universal buffer at pH 5.5 (see methods for 352 
ingredients). It is important to note that pH-induced cysteine modifications have not been 353 
previously described. Deposited EM maps in the electron microscopy data bank (EMDB) mostly 354 
described protein structures at neutral pH and the few maps at lower pH do not possess the 355 
necessary resolution required for this level of comparison with one exception. EMD-4063 (PDB 356 
accession number 5LK7) is the structure of the slow bee paralysis virus virion at pH 5.5 (in 357 
sodium acetate buffer) at a resolution of 3.42 Å. This structure contains five cysteines. While not 358 
discussed in the publication, two of these cysteines, Cys117 and Cys241 in chain A, show 359 
similar modifications as seen in the HBoV maps. The fact that these additional densities were 360 
not observed at pH 7.4 indicates that the low pH may be responsible through the reaction of 361 
glycine or acetate ions react with the thiol group. In future studies, mass spec analyses may 362 
clarify the nature of these cysteine modifications. A low-resolution structure of HBoV2 363 
determined from a sample dialyzed to 2.6 and then back to pH 7.4 did not show the extra 364 
density at the center of the 3-fold axis. This indicates that these modifications are reversible. 365 
The biological significance of these cysteines and their modifications needs to be evaluated 366 
especially given that Cys159 and Cys247/243 showing these densities at pH 2.6 and 5.5 (Fig. 367 
8A, Table 2) are conserved in all HBoVs (28). 368 
HBoV1 and HBoV2 both contain 12 histidines within their VP3 sequence (Table 2). 369 
Among these, there are two conserved pairs with continuous density between them: 370 
H156:H230/226 and H163:H443/439 for HBoV1 and HBoV2, respectively (Fig. 9A, Table 2). At 371 
pH 2.6, additional density occurs between the H156:H230/226 pair in HBoV1 and HBoV2, but 372 
not between the H163:H443/439 pair (Fig. 9A). These "joined" histidine pairs are connected 373 
within the same VP monomer and are conserved in all HBoVs. In addition, a series of “single” 374 
histidines also exhibited modifications at pH 2.6 (Table 2). Conserved histidines in both HBoVs 375 
behaved identical with either both having additional density at pH 2.6, e.g. H497/493 (Fig. 9B), 376 
or both not having additional density, e.g. H515/511. In some cases, aa near histidines with 377 
extra density underwent a conformation change, such as K459 and Y462 near H70 in HBoV2 378 
(Fig. 9B). Interestingly, these residues did not make the same conformational rotation in HBoV1 379 
despite being conserved. In contrast to the cysteines mentioned above, histidines with and 380 
without additional density are found on both the capsid interior and exterior surfaces (Fig. 9C). 381 
Histidines have been shown to change their orientation at different pHs in AAV8 (58). However, 382 
additional density was not reported at low pH in this past study that utilized X-ray 383 
crystallography. Here it is only seen at pH 2.6 (Fig. 9A and B). To our knowledge, no cryo-EM 384 
structure of sufficient resolution has been published at this pH of other parvoviruses and thus 385 
relevance requires further studies beyond the scope of this work. 386 
 In summary, the HBoV2 capsid structure presented here completes the panel for the 387 
currently available HBoV strains. As anticipated, HBoV2 was structurally similar to the other 388 
gastrointestinal HBoVs, HBoV3 and HBoV4, and differs from HBoV1 at VR-III, supporting a role 389 
for this VP region in tissue tropism as originally proposed (28). The capsid dynamics associated 390 
with endo/lysosomal trafficking was documented with HBoV1 and HBoV2 as representatives of 391 
the respiratory and gastrointestinal strains, respectively. Both show similar N-terminal VP 392 
rearrangements and residue level, cysteine and histidine, modifications at specific positions on 393 
the interior and exterior capsid surface. The N-terminal changes support progression towards 394 
the externalization of the PLA2 enzyme required for phospholipid cleavage and escape to the 395 
cytosol or interaction with the nuclear membrane. The modifications are reversible, suggesting 396 
that they may be required for interaction with other molecules in vesicle membranes. Following 397 
escape from the endo/lysosomal pathway, the HBoV capsid reverts to protecting the packaged 398 
genome and trafficking to the nucleus for genome replication.   399 
Methods 400 
HBoV VLP generation and purification. The baculovirus-expression system in Sf9 401 
(Spodoptera frugiperda) cells was used to express VLPs of HBoV1 and HBoV2. Briefly, 250 ml 402 
of Sf9 cells (1.7~2.0x106 cells/ml) were infected by a recombinant baculovirus expressing 403 
HBoV1 or HBoV2 VP3 at a multiplicity of infection of 5 and incubated at 28°C for 3 days. The 404 
infected cells were lysed by three rounds of freeze/thaw cycles in TNET buffer (50 mM Tris-HCl, 405 
pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.2% Triton X-100). After the third cycle, the completely 406 
thawed pellet was treated with Benzonase (250 U/µl, 1 µl/ml sample) to remove nucleic acid. 407 
The VLPs were pelleted through a 20% sucrose (w/v, in TNET) cushion centrifugation at 45,000 408 
rpm for 3 h at 4°C. Subsequently, the pelleted VLPs were resuspended in TNTM buffer and 409 
further purified by sucrose gradient (5% to 40% sucrose [wt/vol] in TNTM buffer (25 mM Tris-410 
HCl, pH 8.0, 100 mM NaCl, 2 mM MgCl2, 0.2% Triton X-100), centrifugation at 35,000 rpm for 3 411 
h at 4°C. 20-25%, 25-30%, and 30-35% fractions of sucrose gradient were collected and 412 
analyzed for the presence of VLPs. The fractions were dialyzed three times into 1×PBS 413 
(phosphate buffer saline, pH 7.4) at 4°C for 3 h each and concentrated to ~1-2 mg/mL using an 414 
Apollo concentrator column. SDS-PAGE and negative-stain EM using a Tecnai G² Spirit TEM 415 
(FEI Co.) were used to analyze the purity and VLP integrity, respectively, as described 416 
previously (56). Alternatively, the purified HBoV1 or HBoV2 samples were dialyzed into glycine-417 
HCl (50 mM glycine, adjusted to pH 2.6) or universal buffer (20 mM HEPES, 20 mM MES, 20 418 
mM sodium acetate, 150 mM NaCl, 5 mM CaCl2) adjusted to a pH of 4.0, 5.5, 6.0, or 7.4, 419 
respectively. All pH treated VLP samples were analyzed by SDS-PAGE and negative-stain EM 420 
prior to 3D structure determination. 421 
 422 
Cryo-EM and Data Collection. HBoV1 VLPs (~1 mg/ml) were applied to C-flat holey carbon 423 
grids (Protochips, Inc.) while HBoV2 VLPs were applied to a thin carbon coated over holey 424 
QUANTIFOIL® grids to overcome aggregation. The samples were vitrified using a Vitrobot™ 425 
Mark IV (FEI Co.) and screened on a 16-megapixel CCD camera (Gatan, Inc.) in a Tecnai (FEI 426 
Co.) G2 F20-TWIN Transmission Electron Microscope (200 kV, ~ e-/Å2) prior to data collection. 427 
For high resolution data collection of HBoV2 at pH 7.4 micrographs were collected by using a 428 
Titan Krios electron microscope (FEI Co.) operating at 300 kV with a DE20 (Direct Electron) 429 
direct electron detector. This data set was collected as part of the NIH Southeastern Center for 430 
Microscopy of MacroMolecular Machines (SECM4) project. For the HBoV VLPs at low pH 431 
conditions data was collected using a Titan Krios electron microscope on a K2 Summit (Gatan) 432 
direct electron detector at the UMASS Cryo-EM core. Images were recorded as ‘movies’ 433 
consisting of multiple frames and their parameters are summarized in Table 1. Subsequently, 434 
the frames of the micrographs were aligned for motion correction and to enhance the signal-to-435 
noise ratio by using the DE_process_frames software (Direct Electron) with corresponding dark 436 
and bright reference images without radiation dose damage compensation for the data collected 437 
on the DE20 direct electron detector (59). The frames collected on the K2 Summit direct 438 
electron detector were aligned using MotionCor2 (60). 439 
 440 
Structure Determination of HBoV VLPs. For the 3D image reconstruction of HBoV1 and 441 
HBoV2 at the different pH conditions the cisTEM software package was utilized (61). Briefly, the 442 
aligned micrographs were imported into the program and their contrast transfer function (CTF) 443 
parameters estimated. The CTF information was used to eliminate micrographs of poor quality. 444 
This was followed by automatic capsid picking using a radius of 125 Å. The selected capsids for 445 
each data set were subjected to 2D classification that eliminated ice particles and debris from 446 
the automatic picking process. Following 2D classification, the structures were reconstructed 447 
using default settings. This included ab initio 3D model generation, auto refinement, and density 448 
map sharpening with a pre-cut off (low resolution amplitudes) B-factor value of -90 Å2, and 449 
variable post-cut off (high resolution amplitudes) B-factor values such as 0, 20, and 50 Å2. The 450 
sharpened density maps were inspected in the Coot and Chimera applications (62, 63). The -90 451 
Å2 (pre-cut off) and 0 Å2 (post-cut off) sharpened maps were used for assignment of the amino 452 
acid main- and side chains for the majority of the capsid. For the more disordered surface loops, 453 
VR-I and VR-V (particularly at pH 7.4 and pH 2.6), the -90 Å2 (pre-cut off) and 50 Å2 (post-cut 454 
off) sharpened maps were used, which were less noisy and allowed a better assignment of the 455 
amino acid main chain in these VP regions. The resolution of the cryo-reconstructed maps was 456 
estimated based on a Fourier shell correlation (FSC) of 0.143 (Table 1). 457 
 458 
VP3 Model Building and Structure Refinement. A model of the HBoV2 VP3 monomer was 459 
generated based on the protein sequence (NCBI accession number: AFW98869.1) on the 460 
SWISS-MODEL protein structure homology-modelling server (https://swissmodel.expasy.org/) 461 
(64) using the structure of HBoV3 as the template (28, 64). The resulting monomer was utilized 462 
to build an icosahedral 60-mer capsid model in VIPERdb (65). The 60-mer capsid model was 463 
docked into the HBoV2 cryo-reconstructed density map using the ‘fit in map’ subroutine in 464 
UCSF-Chimera (63). The quality of the fit between the map and the model was evaluated by a 465 
correlation coefficient (CC) calculation. The pixel size of the reconstructed map was adjusted to 466 
obtain the best fit of the 60-mer model in the reconstructed map. Using the e2proc3d.py 467 
subroutine in EMAN2 and the program MAPMAN, a CCP4 format map file with the correct pixel 468 
size was generated that also represents a compatible file type for Coot (66-68). In Coot the 469 
reference VP3 model was fitted into the density map by adjusting the position of residues 470 
through interactive model building and the real-space-refine options (66). For the HBoV capsids 471 
at low pH conditions, the pH 7.4 VP3 model was fitted into the maps as described above and 472 
structural rearrangements refined in Coot using the real-space-refine option. All VP3 models 473 
were further refined using PHENIX real space refinement with the default settings (69). The 474 
resulting model was analyzed in Coot with the density map and side chains were modified if 475 
necessary. Finally, a B-factor refinement of the models was conducted in PHENIX. 476 
 477 
Structure Alignment of HBoVs. For comparative analysis, the VP3 structures of HBoV1-4 or 478 
of the HBoV1 and HBoV2 at the different pH conditions, were superimposed with each other by 479 
using the secondary structure matching (SSM) program in Coot (70). The program also 480 
calculated root mean square deviations (RMSDs) for the superposed structures and the 481 
distances between the aligned Cα positions. The cartoon representations of the VP3 structures 482 
and side chain density images were generated in Chimera (63). 483 
 484 
Fluorescent Labeling of VLPs. 300-500 µl of purified HBoV1, HBoV2, AAV2, and AAV5 VLPs 485 
(0.5-0.8 mg/ml) were labeled using the DyLight 488 antibody labeling kit (Thermo Fisher) as 486 
described previously (71). Unbound dye was removed by repeated dialysis. The success of 487 
capsid labeling was confirmed by SDS-PAGE and analysis of the gel on a UV transilluminator. 488 
Labeled VLPs were aliquoted and stored until usage at -80°C.  489 
 490 
Cell Lines and Cell Binding Assay. The CHO cell lines Pro5, Lec2, and Lec8 were cultured as 491 
monolayers in MEM-α with 10% FBS (fetal bovine serum) and 1% Antibiotic-Antimycotic (Gibco) 492 
in a 5% CO2 37°C incubator. For cell binding assays, the cells were diluted to 5×105 cells/ml, 493 
pre-chilled for 30 min at 4°C and aliquoted in 500 µl fractions. Each tube of cells was then 494 
incubated with the fluorescently labeled VLPs at a MOI of 106 under constant rotation for 3~4 h 495 
at 4°C. Following the incubation, the cells were pelleted at 2000 rpm for 10 min and the 496 
supernatant discarded. Unbound VLPs were removed by washing the cells with 300 µl ice-cold 497 
1×PBS, followed by another centrifugation. Pellets were resuspended in 300 µl 1×PBS and 498 
analyzed by fluorescence-activating cell sorting (FACs) utilizing a FACS Calibur (Becton & 499 
Dickinson). 500 
 501 
Heparin Binding Assay. Microspin columns (BioRad) were washed with 200 µl TNTM buffer 502 
followed by 1 ml 1×TD buffer (1×PBS with 1 mM MgCl2, 2.5 mM KCl). Then 50 µl of heparin-503 
conjugated agarose type I resin (Sigma) was loaded into the columns. The affinity columns were 504 
equilibrated with 1 ml of 1×TD buffer and charged by washing with 500 µl of 1×TD/1 M NaCl 505 
buffer followed by three sequential washes with 1 ml of 1×TD buffer. Subsequently, 10 µg of 506 
HBoV1, HBoV2, AAV5, and AAV2 VLPs were diluted in 60 µl 1×TD buffer respectively and 30 µl 507 
of the samples loaded onto the columns followed by sequential collection of flow through, five 508 
column washes with 1×TD buffer (30 µl each), and five elution fractions with 1×TD/1 M NaCl 509 
buffer (30 µl each). All fractions were analyzed by SDS-PAGE. 510 
 511 
Differential Scanning Fluorescent (DSF) Stability Assay. Purified HBoV and AAV5 VLPs 512 
(72) were diluted to ~0.2 mg/ml in 1× PBS buffer and then dialyzed in universal buffer to pHs of 513 
4.0, 5.5, 6.0, or 7.4 or glycine-HCl at pH 2.6, respectively. For the DSF assay 2.5 µl of 1% 514 
SYPRO-Orange dye (Molecular Probes, Invitrogen) was added to 22.5 µl of dialyzed sample. 515 
The assay was conducted in a thermocycler (BioRad CFX Connect) with the temperature 516 
ramped from 30 to 99 °C, increasing by 0.1 degrees every 6 s. The melting temperature (TM) for 517 
each sample was defined as the vertex of the first derivative (dF/dT) of relative fluorescence unit 518 
(RFU) values. 519 
 520 
Structure accession numbers  521 
The HBoV1 and HBoV2 cryo-EM reconstructed density maps and models built for their capsids 522 
were deposited in the Electron Microscopy Data Bank (EMDB) with accession numbers EMD-523 
XXXXX/PDB ID XXXX (HBoV1 pH5.5), EMD-XXXXX/PDB ID XXXX (HBoV1 pH2.6), EMD-524 
XXXXX/PDB ID XXXX (HBoV2 pH7.4), EMD-XXXXX/PDB ID XXXX (HBoV2 pH5.5), and EMD-525 
XXXXX/PDB ID XXXX (HBoV2 pH2.6), respectively. 526 
 527 
Acknowledgements  528 
The authors thank the electron microscopy core of the University of Florida (UF) Interdisciplinary 529 
Center for Biotechnology Research (ICBR) for access to electron microscopes utilized for 530 
negative stain electron microscopy and cryo-EM data collection. The Spirit and TF20 cryo-531 
electron microscopes were provided by the UF College of Medicine (COM) and Division of 532 
Sponsored Programs (DSP). The University of Florida COM and NIH GM082946 (to MAM and 533 
RM) provided funds for the research efforts at the University of Florida. We thank the NIH 534 
“Southeastern Center for Microscopy of MacroMolecular Machines (SECM4)” project for access 535 
to the Titan Krios and DE20 DED utilized for high-resolution data collection of the HBoV2 pH7.4 536 
data set. This data collection was made possible by NIH grants S10 OD018142-01 Purchase of 537 
a direct electron camera for the Titan-Krios at FSU (PI Taylor), S10 RR025080-01 Purchase of 538 
a FEI Titan Krios for 3-D EM (PI Taylor), and U24 GM116788 The Southeastern Consortium for 539 
Microscopy of MacroMolecular Machines (PI Taylor). We thank the University of Massachusetts 540 
Medical School Cryo-EM Center funded by Massachusetts Life Sciences Center and Howard 541 
Hughes Medical Institute. The Titan Krios was acquired through funds a capital grant through 542 
Massachusetts Life Sciences Center's Competitive Capital Program and by a HHMI 543 
Transformative Technology (TT16) Award. The Sigrid Jusélius Foundation and the Life and 544 
Health Medical Grant Association provided funds for the research efforts at the University of 545 
Helsinki, Finland (to MS-V). 546 
 547 
Author contributions  548 
M.L. was responsible for VLP production, purification, and dialysis to the desired pH condition, 549 
fluorescent labeling of VLPs, the execution of the cell and heparin binding assays, DSF assay, 550 
initial structure determinations using reconstruction by cryo-EM, and wrote a first draft of the 551 
manuscript. M.M. was responsible for cell binding assay analysis, cryo-reconstruction, structure 552 
refinement and analysis, model building and refinement, and manuscript preparation. P.C. 553 
vitrified sample, frozen, and screened cryo-EM grids. C.X., J.S. and D.S. collected cryo-EM 554 
data. R.M. and M.S-V. contributed to interpretation of the results and manuscript preparation. 555 
M.A-M. conceived and designed the project, analyzed all results, and contributed to manuscript 556 
preparation. All authors have read and agreed to the published version of the manuscript. 557 
 558 
Competing interests  559 
The authors declare no conflict of interest. 560 
 561 
Figure Legends: 562 
Fig. 1: The HBoV2 capsid structure. A) The reconstructed capsid surface map colored 563 
according to radial distance from the capsid center (blue) to outermost regions (red) as 564 
indicated by the scale bar. B) Cross-sectional view of the capsid. Locations of the 5-fold channel 565 
(5f), 3-fold (3f), 2-fold (2-f) axes, and 2/5-fold wall are indicated by arrowheads. Density coloring 566 
is as in (A). C) Example of fitted amino acid residues, W94 - N98¸ in βC strand. The density map 567 
depicted as a black mesh. The VP model is shown in stick representation and the atoms are 568 
colored: C: yellow; O: red, N: blue. D) Closeup of a cross-sectional view of "the basket" under 569 
the 5-fold channel (refer to panel B). The ribbon diagram of VP3 is shown within the 570 
semitransparent density. The first ordered residue G33 is labeled. This figure was generated 571 
using UCSF-Chimera (63). 572 
Fig. 2: HBoV2 VP structure. A) Ribbon diagram of HBoV2 VP structure. The conserved β-barrel 573 
core motif (βB-I), βA strand, αA and αB helices are indicated. The N- and C-terminal are 574 
labeled. The loops inserted between these secondary structure elements also contain β-strand 575 
regions, as indicated. B) Structural superposition of HBoV1 (blue), HBoV2 (orange), HBoV3 576 
(green), and HBoV4 (red), with the location of variable loops VR-I to IX labeled. The 577 
approximate icosahedral 2-, 3-, and 5-fold axes are indicated as a filled oval, triangle, and 578 
pentagon, respectively. The images were generated with PyMOL (73). 579 
Fig. 3: Glycan binding analysis of HBoV1 and HBoV2. A) SDS-PAGE of heparin binding assay 580 
fractions for AAV2, AAV5, HBoV1, and HBoV2 VLPs. FT: flow-through, W1-5: wash fraction; 581 
E1-5: elution fractions. B) SDS-PAGE of labeled HBoV1, HBoV2, AAV2, and AAV5 VLPs. Gels 582 
(left) stained for proteins shows the presence of VP3 of HBoV1 and HBoV2 (~60kDa) as well as 583 
VP1 (~87 kDa), VP2 (~72 kDa) and VP3 (~62 kDa) of AAV2 and AAV5 (AAV5 VP1 is low 584 
concentration). Gels (right) imaged under UV light to confirm successful fluorescent capsid 585 
labeling. C) Cell binding assay analysis of fluorescently-labeled VLPs incubated with the 586 
indicated cell lines. Results show the percentage of cells bound by the fluorescently-labeled 587 
capsids and displayed as mean ± standard deviation (n=3). 588 
Fig. 4: HBoV capsids under different pH conditions. Negative-stain EM analysis of HBoV1 (A) 589 
HBoV2 (B) capsids dialyzed into indicated pH. Sample labeled 2.6>7.4 was dialyzed to pH 2.6 590 
then subsequently re-dialyzed to pH 7.4. C) Capsid stability analysis using differential scanning 591 
fluorimetry. The melting temperature (TM) of HBoV1, HBoV2, and AAV5 capsids were 592 
determined at pH 2.6, 4.0, 5.5, 6.0, and 7.4. Results are displayed as mean ± standard 593 
deviation (n=3). 594 
Fig. 5: Capsid density maps of HBoV1 and HBoV2. HBoV1 structures at pH 7.4, 5.5, and 2.6 595 
are shown on the left-hand side. Similar pH structures for HBoV2 are shown on the right-hand 596 
side. The reconstructed maps are colored according to radial distance (blue to red), as indicated 597 
by the scale bar below. Shown are surface and cross-sectional views of HBoV1 and 2 at the 598 
different pH conditions indicated. The images were generated with UCSF-Chimera (63). 599 
Fig. 6: VP structure of HBoV1 and HBoV2 at varying pHs. A) Conformation of VR-I in HBoV1 at 600 
pH 7.4 (blue), 5.5 (yellow-orange) and 2.6. (red) shown as coil diagrams. Amino acid side 601 
chains are shown within the corresponding density map for each pH condition. B) Conformation 602 
of VR-I in HBoV2 shown as in (A). C) Conformation of VR-V in HBoV1 and D) HBoV2 presented 603 
as in (A). E) Superposition of the HBoV1 and F) HBoV2 VP structures at the different pH 604 
conditions. The positions of VR-I to VR-IX, the N-, and C-terminus are labeled. The images 605 
were generated with UCSF-Chimera (63). 606 
Fig. 7: The structures of the N-termini of HBoV1 and HBoV2 at varying pHs. A) Cross-sectional 607 
views of the HBoV1 density maps and fitted models shown as ribbon diagrams for each pH 608 
condition (pH 7.4 – blue; pH 5.5 – yellow-orange; and pH 2.6 – red) studied. The 5-fold 609 
symmetry axis, glycine 33, and β-strand G are indicated. B) The amino acids of the HBoV1 N-610 
terminus and β-strand G are shown in stick representation inside the pH 2.6 mesh density map. 611 
C) Cross-sectional views of HBoV2 as in (A) and D) the amino acids of the HBoV2 N-terminus 612 
and β-strand G inside the pH 2.6 mesh density map as in (B). E) Representation of the interior 613 
surface of the HBoV1 or F) HBoV2 capsid from a 9-mer at a pH of 2.6. At this condition, the N-614 
terminus is extending away from the 5-fold channel. The N-terminal residue, G33, are colored 615 
red and the last N-terminal residue ordered, 24, are colored blue. The asymmetric unit, the 2-, 616 
and 3-fold symmetry axes is indicated. Panel A-D were generated with UCSF-Chimera (63) and 617 
E-F with PyMOL (73). 618 
Fig. 8: Modification of cysteines at low pH conditions. A) HBoV1 and HBoV2 model and density 619 
map (black mesh) are shown at pH7.4, 5.5 and 2.6. Additional density relative to pH 7.4 is 620 
indicated as a red mesh. Density meshes are contoured at a σ-level threshold of 2.0. The 621 
additional cysteine density for Cys159 causes F243/239 to flip at pH 5.5 and 2.6, indicated by a 622 
red arrow. B) Similar depiction (as in A) for cysteines with additional densities exclusively at pH 623 
2.6. In HBoV2 C393 causes extra density at the center of the 3-fold symmetry axis. The view is 624 
rotated by 90o without density mesh for the VP3 amino acids. The images were generated with 625 
UCSF-Chimera (63). (C and D) Position of cysteines on the exterior and interior surface of 626 
HBoV1 and HBoV2 capsids. Cysteines labeled red indicate that these possess additional 627 
densities whereas cysteines in blue display no additional densities. The images were generated 628 
with PyMOL (73). 629 
Fig. 9: Modification of histidines at low pH conditions. A) HBoV1 and HBoV2 paired-histidines 630 
and density (black mesh) are shown at pH7.4, 5.5 and 2.6. Additional density relative to pH 7.4 631 
is indicated as a red density mesh. Density meshes are shown at a σ-level threshold of 2.0. The 632 
movement of H230 indicated by a red arrow. B) Similar depiction (as in A) for “single” histidines. 633 
The conformation change to Y462 at pH2.6 is indicated by a red arrow. The images were 634 
generated with UCSF-Chimera (63). (C and D) Position of histidines on the exterior and interior 635 
surface of HBoV1 or HBoV2 capsids. Histidines labeled red indicate that these possess extra 636 
densities, in orange the paired H163 with H443/439 and in blue histidines that displayed no 637 
additional densities. The images were generated with PyMOL (73).  638 





  644 
 HBoV1 HBoV2 
 pH 2.6 pH 5.5 pH 2.6 pH 5.5 pH 7.4 
Total number of 
micrographs 785 711 691 927 2,921 
Defocus range (µm) 0.84 - 4.03 0.82 - 3.74 0.83 - 4.02 0.82 - 4.03 0.78-4.39 
Electron dose (e- / Å2) 32 32 32 32 64 
Frames / micrograph 50 50 50 50 36 
Pixel size (Å / pixel) 0.90 1.04 0.90 0.91 0.96 
Particles used for final 
map 50,342 66,471 19,648 30,308 188,857 
Resolution of final map (Å) 2.54 2.74 2.51 2.74 2.71 
PHENIX model refinement statistics 
Map CC 0.81 0.80 0.84 0.87 0.83 
RMSD [bonds] (Å) 0.01 0.01 0.01 0.01 0.01 
RMSD [angles] (Å) 0.85 0.84 0.88 0.84 0.81 
All-atom clash score 11.88 10.55 9.66 8.17 10.17 
Ramachandran plot  
          Favored (%) 96.7 95.9 96.9 97.2 96.8 
          Allowed (%) 3.3 4.1 3.1 2.6 3.2 
          Outliers (%) 0 0 0 0.2 0 
Rotamer outliers (%) 0.5 0.2 0.2 0.2 0.2 
C-β deviations 0 0 0 0 0 





comment pH   
7.4 
pH   
5.5 
pH   
2.6 
pH    
7.4 
pH   
5.5 
pH   
2.6 
C89 no no yes   C89 no yes yes causes flip of K262 
C104 no no yes density to C477, M177  S104 N/A N/A N/A   
C159 no yes yes causes flip of F243 C159 no yes yes causes flip of F239 
C247 no yes yes  C243 no yes yes  
C322 no no yes  V318 N/A N/A N/A   
C347 no no yes   S343 N/A N/A N/A   
V397 N/A N/A N/A   C393 no no yes density at 3-fold 
C421 no no yes density towards H170 C417 no weak yes density towards H170 
C471 no no no   C467 no no no   
C477 no no yes density to C104, M177  C473 no no no   
C531 no no no   C527 no no no   
  
H48 no no no   Y48 N/A N/A N/A   
H70 no no yes   H70 no no yes flip of K450 / Y462 nearby 
H105 yes yes yes coordinated ion? H105 yes yes yes  coordinated ion? 
Q127 N/A N/A N/A   H127 no no yes shift of K129 nearby 
H156 no no yes paired with H230 H156 no yes yes paired with H226 
H163 no no yes paired with H443 H163 yes yes yes paired with H439 
H170 no weak yes  density towards C421 H170 no weak yes density towards C417 
N197 N/A N/A N/A   H197 no no no   
H230 no no yes paired with H156 H226 yes yes yes paired with H156 
N278 N/A N/A N/A   H274 no no †  
H329 † no †  A325 N/A N/A N/A   
H429 no no yes   N425 N/A N/A N/A   
H443 no no yes paired with H163 H439 yes yes yes paired with H163 
H497 no no yes   H493 no no yes   
H515 no no no   H511 no no no   
† local resolution not sufficient to determine whether extra density is present 646 
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